Hydroxychloroquine prophylaxis for COVID-19 contacts in India

Lancet Infect Dis. 2020 Oct;20(10):1118-1119. doi: 10.1016/S1473-3099(20)30313-3. Epub 2020 Apr 17.

Authors

Sahaj Rathi¹, Pranav Ish², Ashwini Kalantri³, Shriprakash Kalantri⁴

Affiliations

¹ Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India.
² Department of Pulmonary Medicine, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
³ Department of Community Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India.
⁴ Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India. Electronic address: [email protected].

No abstract available

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Chloroquine / supply & distribution
Chloroquine / therapeutic use
Contact Tracing
Coronavirus Infections / drug therapy
Coronavirus Infections / prevention & control*
Family Characteristics
Humans
Hydroxychloroquine / supply & distribution
Hydroxychloroquine / therapeutic use*
India
Pandemics / prevention & control*
Pneumonia, Viral / prevention & control*
Pre-Exposure Prophylaxis*
SARS-CoV-2

Substances

Hydroxychloroquine
Chloroquine